NEWS 9/30/08:
Tianyin Pharmaceutical Co., Inc. to Begin Trading on the American Stock Exchange on October 1, 2008
New Ticker 'TPI'
CHENGDU, China, Sept 30, 2008 /Xinhua-PRNewswire-FirstCall via COMTEX/ -- Tianyin Pharmaceutical, Co., Inc., (OTC Bulletin Board: TYNP - News), a manufacturer and supplier of modernized traditional Chinese medicine ("TCM") based in Chengdu, China, today announced that its common stock will begin trading on the American Stock Exchange (the "AMEX") under the ticker "TPI" at market open on Wednesday, October 1, 2008.
"Moving to the AMEX is a landmark for our Company. We expect that trading on the AMEX will elevate our Company's standing within the international business community, as well as our visibility among the investment community," Dr. Jiang, Chairman and CEO of Tianyin commented. "I would like to thank both Tripoint Capital Advisors, the financial advisor for Tianyin Pharmaceuticals, and CMARK Capital, Tripoint's partner in China, for being instrumental with the transition and activities since our Company became public."
The AMEX Panel's approval is contingent upon the Company being in direct compliance with the Alternative Listing Standards at the time the Company's common shares begin trading on the AMEX, and may be rescinded if the Company is not in compliance with such standards. Once Tianyin's common shares commence trading on the AMEX, the Company will enjoy all of the same privileges and be subject to all of the same regulations as any other company whose shares are listed on the AMEX, regardless of the Listing Standard used to determine the Company's eligibility.
The Pulse of IHUB and "The Heartbeat of the SmallCap and MicroCap Community!"TM
